RM-493-042
This is an open-label extension study designed to evaluate the long-term safety and tolerability of continued setmelanotide treatment in male and female patients ≥2 years of age who have completed or transitioned from a previous study with…
- Investigator
- Jennifer L Miller
- Status
- Accepting Candidates
- Ages
- 2 Years - N/A
- Sexes
- All
RM-493-040
- Investigator
- Jennifer L Miller
- Status
- Accepting Candidates
C614
The purpose of this is study is to evaluate the long-term safety of DCCR (diazoxide choline) extended-release tablets) in patients with Prader-Willi syndrome.
- Investigator
- Jennifer L Miller
- Status
- Accepting Candidates
- Ages
- 4 Years - N/A
- Sexes
- All